FDA Approvs for New Blood Thinner For Knee and Hip Replacements
The drug was not theirs though as it came from Bayer Healthcare who already markets the drug in other countries and the market name for rivaroxaban, the Bayer drug, under…
Welcome New Interns and Residents
Another July 1st arrives at the Medical Centers of America. Educated observers remark at the fresh neatly pressed white coats entering the hospital. At the same time these fresh young…
Before and After Regenerative Stem Cell Treatment in Mexico – A Patient Talks
This is interesting to listen to the man from Canada who traveled to Mexico for treatment and it’s pretty astounding when he talks about what he couldn’t do before and…
ACO’s and CMS
The Accountable Care Organization is really an accounting mechanism and may have little to do with quality of care, or improving outcomes. Commonly called, “ACO” in health care circles…
Pharma R & D Spending is Down
And that’s probably bad news. Here is Megan McArdle, writing in The Atlantic: For the first time ever last year, the global drug industry cut its R&D spending. The trend…
ePatient Dave is In The Room (video)
Some of us talk about the “elephant in the room’ which everyone knows about but ignores. We also may make the same mistake about the person across from you…
The Battle Over Avastin
The use of Avastin for breast cancer was addressed by the U.S. Food and Drug Administration this week. The outcome was devastating for Roche and an emotional one for many…
Big Box Retailer Forms Unlikely Alliance with Goal of Streamlining Medicaid Policy
For the first time, a major private coporation is partnering with a local hospital in assisting Medicaid beneficiaries in obtaining legal assistance in squabbles with the entitlement over public health care…
Who Will Drive Social Media Use in Health Care? Part 1
In his blog post titled Social Media in Health Care: Barriers and Future Trends, author John Sharp notes that social media has invaded health care from at least three fronts: …
#Bio2011: After the Party is Over
For the thousands of life science industry representatives who attend the Biotechnology Industry Organization Annual Convention each year, the last few days have been similar to a favorite ho For the thousands…
